Published in Pharmacol Rev on March 01, 1998
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Cardiovascular biology of the incretin system. Endocr Rev (2012) 2.42
From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat Neurosci (2012) 2.26
Drosophila neuropeptide F and its receptor, NPFR1, define a signaling pathway that acutely modulates alcohol sensitivity. Proc Natl Acad Sci U S A (2005) 1.78
Gastrointestinal hormones regulating appetite. Philos Trans R Soc Lond B Biol Sci (2006) 1.47
Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol (2006) 1.24
The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology (2011) 1.21
Glial-derived neurotrophic factor modulates enteric neuronal survival and proliferation through neuropeptide Y. Gastroenterology (2006) 1.16
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol (2000) 1.16
Neuropeptide Y receptor gene expression in the primate amygdala predicts anxious temperament and brain metabolism. Biol Psychiatry (2013) 1.14
The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci (2008) 1.14
Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone (2008) 1.13
Tobacco addiction and the dysregulation of brain stress systems. Neurosci Biobehav Rev (2012) 1.09
Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa. Br J Pharmacol (2002) 1.09
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol (2000) 1.08
Musings on the wanderer: what's new in our understanding of vago-vagal reflexes? III. Activity-dependent plasticity in vago-vagal reflexes controlling the stomach. Am J Physiol Gastrointest Liver Physiol (2003) 1.07
Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons. Proc Natl Acad Sci U S A (2002) 1.07
Neuropeptide Y: A hypothalamic brake restraining the onset of puberty in primates. Proc Natl Acad Sci U S A (2000) 1.06
Obesity and appetite control. Exp Diabetes Res (2012) 1.05
Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol (2000) 1.03
Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus. J Physiol (2003) 1.02
Peptides and food intake. Front Endocrinol (Lausanne) (2014) 1.01
Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension. Hypertension (2008) 1.01
Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth. Can J Physiol Pharmacol (2008) 0.99
Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues. Br J Pharmacol (2003) 0.98
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc Natl Acad Sci U S A (2000) 0.98
Neuropeptide Y directly inhibits neuronal activity in a subpopulation of gonadotropin-releasing hormone-1 neurons via Y1 receptors. Endocrinology (2010) 0.98
Neuropeptide Y and Epilepsy. Epilepsy Curr (2003) 0.97
Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246. Br J Pharmacol (2002) 0.97
Molecular mechanisms of appetite regulation. Diabetes Metab J (2012) 0.97
Modulation of inhibitory neurotransmission in brainstem vagal circuits by NPY and PYY is controlled by cAMP levels. Neurogastroenterol Motil (2009) 0.96
NPY receptors as potential targets for anti-obesity drug development. Br J Pharmacol (2011) 0.96
Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience (2008) 0.95
Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br J Pharmacol (2003) 0.95
Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner. Behav Brain Res (2009) 0.94
Neuropeptide Y receptors: how to get subtype selectivity. Front Endocrinol (Lausanne) (2013) 0.94
Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice. Am J Physiol Gastrointest Liver Physiol (2009) 0.93
Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proc Natl Acad Sci U S A (2006) 0.92
Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1 and Y2 receptors in rat thalamic neurons. J Physiol (2001) 0.91
[(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors. Br J Pharmacol (2000) 0.91
Quantitative analysis of neuropeptide Y receptor association with beta-arrestin2 measured by bimolecular fluorescence complementation. Br J Pharmacol (2010) 0.90
Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction. Mol Cell Endocrinol (2008) 0.89
Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries. Br J Pharmacol (2000) 0.89
The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors. Br J Pharmacol (2005) 0.89
beta-Adrenergic activation of electrogenic K+ and Cl- secretion in guinea pig distal colonic epithelium proceeds via separate cAMP signaling pathways. Am J Physiol Gastrointest Liver Physiol (2010) 0.88
Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav (2008) 0.88
Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo. Br J Pharmacol (2001) 0.88
Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein. J Biol Chem (2009) 0.88
Peptide regulators of peripheral taste function. Semin Cell Dev Biol (2013) 0.87
Neuropeptide Y enhances olfactory mucosa responses to odorant in hungry rats. PLoS One (2012) 0.87
Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice. Neuropharmacology (2008) 0.87
NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons. Neuropsychopharmacology (2013) 0.85
Action of Neurotransmitter: A Key to Unlock the AgRP Neuron Feeding Circuit. Front Neurosci (2013) 0.85
Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84
Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study. Am J Cardiovasc Dis (2011) 0.83
Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge. J Psychopharmacol (2009) 0.83
A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress. Br J Pharmacol (2012) 0.83
G-protein-coupled receptors in adult neurogenesis. Pharmacol Rev (2012) 0.83
Modulation of taste responsiveness by the satiation hormone peptide YY. FASEB J (2013) 0.83
Evolution of the neuropeptide Y receptor family: gene and chromosome duplications deduced from the cloning and mapping of the five receptor subtype genes in pig. Genome Res (2000) 0.83
Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells. Hypertension (2012) 0.83
Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines. Br J Pharmacol (2001) 0.83
BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. Br J Pharmacol (2005) 0.83
Body composition and skeletal health: too heavy? Too thin? Curr Osteoporos Rep (2012) 0.82
Hypothalamic neuropeptide signaling in alcohol addiction. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.82
The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors. Br J Pharmacol (2003) 0.82
Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism? Naunyn Schmiedebergs Arch Pharmacol (2008) 0.82
Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.82
Taste perception, associated hormonal modulation, and nutrient intake. Nutr Rev (2015) 0.81
Diet in irritable bowel syndrome. Nutr J (2015) 0.81
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome. Clin Exp Pharmacol Physiol (2010) 0.81
Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice. Synapse (2009) 0.81
A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R. BMC Med Genet (2004) 0.81
Central hypotensive effects of neuropeptide Y are modulated by endothelial nitric oxide synthase after activation by ribosomal protein S6 kinase. Br J Pharmacol (2012) 0.81
Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice. J Psychopharmacol (2009) 0.81
Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: desensitization via the Y2-neuropeptide receptor. Am J Physiol Gastrointest Liver Physiol (2009) 0.81
The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Acta Physiol (Oxf) (2015) 0.81
Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours. Br J Cancer (2000) 0.81
Neuropeptide y gates a stress-induced, long-lasting plasticity in the sympathetic nervous system. J Neurosci (2013) 0.81
The neuropeptide Y monomer in solution is not folded in the pancreatic-polypeptide fold. Protein Sci (2002) 0.80
Neuropeptide Y stimulates autophagy in hypothalamic neurons. Proc Natl Acad Sci U S A (2015) 0.80
The endocrinology of taste receptors. Nat Rev Endocrinol (2015) 0.80
Novel neuropeptide Y Y2-like receptor subtype in zebrafish and frogs supports early vertebrate chromosome duplications. J Mol Evol (2004) 0.80
Control of signalling efficacy by palmitoylation of the rat Y1 receptor. Br J Pharmacol (2003) 0.80
Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats. Br J Pharmacol (2006) 0.80
Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake. Neuropeptides (2009) 0.80
NPY receptor subtype in the rabbit isolated ileum. Br J Pharmacol (1999) 0.80
Role of RACK1 in the differential proliferative effects of neuropeptide Y(1-36) and peptide YY(1-36) in SHR vs. WKY preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol (2013) 0.80
The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts. PLoS One (2012) 0.80
Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig. Br J Pharmacol (2002) 0.79
Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers. EJNMMI Res (2011) 0.79
NPY and NPY receptors in airway structural and inflammatory cells in allergic asthma. Exp Mol Pathol (2012) 0.79
Role of peptide YY(3-36) in the satiety produced by gastric delivery of macronutrients in rats. Am J Physiol Endocrinol Metab (2013) 0.79
Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes. Cell Signal (2014) 0.79
Intracellular nitric oxide mediates neuroproliferative effect of neuropeptide y on postnatal hippocampal precursor cells. J Biol Chem (2012) 0.79
Neuropeptide Y-immunoreactive neurons in the cerebral cortex of humans and other haplorrhine primates. Am J Primatol (2012) 0.78
Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes. Br J Pharmacol (2002) 0.78
Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries. Br J Pharmacol (2004) 0.78
Bowels control brain: gut hormones and obesity. Biochem Med (Zagreb) (2012) 0.77
Pancreatic islet neuropeptide Y overexpression has minimal effect on islet morphology and β-cell adaptation to high-fat diet. Endocrinology (2014) 0.77
Vertebrate genome evolution and the zebrafish gene map. Nat Genet (1998) 5.16
A neural basis for general intelligence. Science (2000) 4.49
Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A (1982) 3.30
cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. Proc Natl Acad Sci U S A (1983) 2.66
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Parents' accounts of obtaining a diagnosis of childhood cancer. Lancet (2001) 2.62
Structure of the murine immune response I-A beta locus: sequence of the I-A beta gene and an adjacent beta-chain second domain exon. Cell (1983) 2.42
Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry (1989) 2.41
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum (2001) 2.37
Mutations and selection in the generation of class II histocompatibility antigen polymorphism. EMBO J (1984) 2.34
Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains. EMBO J (1984) 2.18
Alpha chain of HLA-DR transplantation antigens is a member of the same protein superfamily as the immunoglobulins. Cell (1982) 2.13
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis (2012) 2.09
Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids. J Nucl Med (1991) 2.07
The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci (2000) 2.04
Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev (1997) 1.98
Role of the premotor cortex in recovery from middle cerebral artery infarction. Arch Neurol (1998) 1.94
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A (1995) 1.91
Structure of C-terminal half of two H-2 antigens from cloned mRNA. Nature (1981) 1.90
cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. Proc Natl Acad Sci U S A (1981) 1.90
Epidemiological aspects of cholera El Tor outbreak in a non-endemic area. Lancet (1971) 1.87
Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther (1987) 1.85
Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DC beta gene. Proc Natl Acad Sci U S A (1983) 1.85
Functional anatomy of intrinsic alertness: evidence for a fronto-parietal-thalamic-brainstem network in the right hemisphere. Neuropsychologia (1999) 1.76
The complete nucleotide sequence of the I-E alpha d immune response gene. Nucleic Acids Res (1983) 1.75
Isolation and identification of a cDNA clone corresponding to an HLA-DR antigen beta chain. Proc Natl Acad Sci U S A (1982) 1.75
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol (1993) 1.71
The effects of red bull energy drink on human performance and mood. Amino Acids (2001) 1.71
Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci (1999) 1.66
Sequence of gene and cDNA encoding murine major histocompatibility complex class II gene A beta 2. J Biol Chem (1985) 1.66
The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) (1988) 1.63
Characterization of an HLA DR beta pseudogene. Proc Natl Acad Sci U S A (1985) 1.62
Interpseudophakos Elschnig pearls associated with late hyperopic shift: a complication of piggyback posterior chamber intraocular lens implantation. J Cataract Refract Surg (1999) 1.61
Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation (1997) 1.60
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther (1990) 1.60
The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci (2000) 1.56
Y-receptor subtypes--how many more? Trends Neurosci (1997) 1.55
Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A (1997) 1.55
Fully-3D PET image reconstruction using scanner-independent, adaptive projection data and highly rotation-symmetric voxel assemblies. IEEE Trans Med Imaging (2011) 1.54
The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction. J Nucl Med (1991) 1.51
Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci U S A (1984) 1.48
Structure of the human Ia-associated invariant (gamma)-chain gene: identification of 5' sequences shared with major histocompatibility complex class II genes. Proc Natl Acad Sci U S A (1986) 1.47
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review. Sci Total Environ (2013) 1.47
Necrotising fasciitis. Appropriate skin flap may reduce deformity. BMJ (1994) 1.46
Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain (1990) 1.44
Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor. J Exp Med (1972) 1.43
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol (1994) 1.43
Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci (1999) 1.42
Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther (1989) 1.42
Noninvasive assessment of regional cardiac adenosine using positron emission tomography. J Nucl Med (1992) 1.41
The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis (1990) 1.41
Laser-assisted lead extraction: the European experience. Europace (2007) 1.41
Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. Proc Natl Acad Sci U S A (1981) 1.39
Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity. J Physiol (2003) 1.39
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
An analysis of the negative inotropic action of somatostatin. Br J Pharmacol (1979) 1.37
Inactivation and degradation of messenger ribnucleic acid from the lactose operon of Escherichia coli. J Mol Biol (1970) 1.36
The neural circuitry involved in the reading of German words and pseudowords: A PET study. J Cogn Neurosci (1999) 1.35
The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med (1993) 1.35
Long-range correlations in DNA. Nature (1993) 1.34
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol (1992) 1.33
Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A (1995) 1.33
Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial. J Clin Oncol (2003) 1.31
Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest (1983) 1.30
Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci (2001) 1.30
Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand (1992) 1.29
Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem (2000) 1.29
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem (1992) 1.28
Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br J Pharmacol (1998) 1.28
Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus. J Neurosci Res (1988) 1.27
History of tuberculosis. Respiration (1998) 1.24
Classification of alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol (1995) 1.24
Expression of a conserved cell-type-specific protein in nerve terminals coincides with synaptogenesis. Proc Natl Acad Sci U S A (1991) 1.23
A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) (1989) 1.23
Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci U S A (1987) 1.22
The Zalpha domain from human ADAR1 binds to the Z-DNA conformer of many different sequences. Nucleic Acids Res (1998) 1.21
Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience (2000) 1.21
Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med (1999) 1.21
Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol Sci (1992) 1.21
Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol (1997) 1.20
Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol (2000) 1.20
Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience (2005) 1.20
Expectation maximization reconstruction of positron emission tomography images using anatomical magnetic resonance information. IEEE Trans Med Imaging (1997) 1.20
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. Proc Natl Acad Sci U S A (1996) 1.19
Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience (2002) 1.18
[3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience (1997) 1.17
[New theoretical values in exploration of the respiratory function of the lung]. Bull Physiopathol Respir (Nancy) (1972) 1.17
Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia (2006) 1.16
Embryonic expression of the mRNA for the rat homologue of the fusin/CXCR-4 HIV-1 co-receptor. J Neuroimmunol (1997) 1.16
Distribution and utilization of 15N in cowpeas injected into the stem under influence of water deficit. Isotopes Environ Health Stud (2000) 1.16
Identifying participation rates at outpatient cardiac rehabilitation programs in Victoria, Australia. J Cardiopulm Rehabil (2000) 1.14
The role of diaschisis in stroke recovery. Stroke (1999) 1.14
Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience (2003) 1.13
Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res (1999) 1.13
[Infection experiments with the cotton rat filaria Litomosoides carinii in Mastomys natalensis (Smith, 1834)]. Z Parasitenkd (1968) 1.13
Spectroscopic characterization of a DNA-binding domain, Z alpha, from the editing enzyme, dsRNA adenosine deaminase: evidence for left-handed Z-DNA in the Z alpha-DNA complex. Biochemistry (1998) 1.13
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol (2000) 1.12
Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain. J Comp Neurol (1993) 1.12
Episodic retrieval activates the precuneus irrespective of the imagery content of word pair associates. A PET study. Brain (1999) 1.12
Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem (1995) 1.12